Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-25

Clinical Trial Update: Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free Intervals [NA]

View source ↗

Summary

A completed clinical trial comparing frovatriptan to placebo for the prevention of menstrual migraines during hormone-free intervals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FROVATRIPTAN (FROVATRIPTAN SUCCINATE)

Snippet

Sponsor: Scott and White Hospital & Clinic | Conditions: Migraines, Bleeding | NA | Status: COMPLETED